Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  ANTA PHAR       

ANTA PHAR
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Anthera Pharmaceuticals Inc : Faruqi & Faruqi, LLP is Investigating Anthera Pharmaceuticals Incorporated on Behalf of its Shareholders - ANTH

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/13/2013 | 02:05pm CET

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential claims against the board of directors of Anthera Pharmaceuticals Incorporated ("Anthera" or the "Company") (Nasdaq: ANTH) concerning possible breaches of fiduciary duty and other violations of law related to the Company's compensation packages for its executive officers. The investigation focuses on the approval and awarding of certain stock options to executives that may have violated the Company's compensation plans.

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)

Request more information now by clicking here: www.faruqilaw.com/ANTH

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action and derivative litigation. The firm is focused on providing exemplary legal services in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients.

If you hold ANTH shares and you would like to discuss your legal rights, visit www.faruqilaw.com/ANTH. You can also contact us by calling Michael J. Hynes free at 877-247-4292 or at 215-277-5770 or by sending an e-mail to [email protected]

Contact:

Faruqi & Faruqi, LLP
Michael J. Hynes, Esq.
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Telephone: (877) 247-4292 or (215) 277-5770
E-mail: [email protected]

(Nasdaq: ANTH)

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP


© PRNewswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ANTA PHAR
02/21ANTHERA PHARMACEUTICALS : Why Shares of Anthera Pharmaceuticals are Soaring
AQ
02/09ANTHERA PHARMACEUTICALS : to participate in the BIO CEO and Investor Conference ..
AQ
02/08Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference a..
GL
02/06ANTHERA PHARMACEUTICALS : Concludes Last Patient Visit in the Phase 3 RESULT Cli..
AQ
02/05Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of ..
GL
01/29ANTHERA PHARMACEUTICALS : Receives Positive Nasdaq Listing Determination
AQ
01/26ANTHERA PHARMACEUTICALS,INC. (NASDAQ : ANTH) Files An 8-K Notice of Delisting or..
AQ
01/25ANTHERA PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Contin..
AQ
01/25Anthera Receives Positive Nasdaq Listing Determination
GL
01/25ANTHERA PHARMACEUTICALS INC : Today’s Research Reports on Trending Tickers: Anth..
AC
More news